Related references
Note: Only part of the references are listed.Peripheral Blood Based Discrimination of Ulcerative Colitis and Crohn’s Disease from Non-IBD Colitis by Genome-Wide Gene Expression Profiling
Ferenc Sipos et al.
DISEASE MARKERS (2013)
Second-Generation Corticosteroids for the Treatment of Crohn's Disease and Ulcerative Colitis: More Effective and Less Side Effects?
Chiara De Cassan et al.
DIGESTIVE DISEASES (2012)
TNFα inhibitors restrict T cell activation and cycling via Notch-1 signalling in inflammatory bowel disease
Lael Werner et al.
GUT (2012)
Mucosal healing in inflammatory bowel diseases: a systematic review
Markus F. Neurath et al.
GUT (2012)
Role of serum cytokine profile in ulcerative colitis assessment
Manuel Luis Rodriguez-Peralvarez et al.
INFLAMMATORY BOWEL DISEASES (2012)
Results of the 2nd Scientific Workshop of the ECCO (III): Basic mechanisms of intestinal healing
Florian Rieder et al.
JOURNAL OF CROHNS & COLITIS (2012)
Profiles of circulating cytokines in patients with Crohn's disease under maintenance therapy with infliximab
Kotaro Ogawa et al.
JOURNAL OF CROHNS & COLITIS (2012)
Serum MMPs 7-9 and their inhibitors during glucocorticoid and anti-TNF-α therapy in pediatric inflammatory bowel disease
Laura Makitalo et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
The effect of adalimumab for induction of endoscopic healing and normalization of mucosal cytokine gene expression in Crohn's disease
Renathe Rismo et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Microscopic colitis
Gianluca Ianiro et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
Jean Frederic Colombel et al.
GASTROENTEROLOGY (2011)
Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFα treatment
Claudia Veltkamp et al.
GUT (2011)
Peripheral blood based discrimination of ulcerative colitis and Crohn's disease from non-IBD colitis by genome-wide gene expression profiling
Ferenc Sipos et al.
DISEASE MARKERS (2011)
Disruption of Paneth and goblet cell homeostasis and increased endoplasmic reticulum stress in Agr2-/-mice
Fang Zhao et al.
DEVELOPMENTAL BIOLOGY (2010)
Rapid endoscopic improvement is important for 1-year avoidance of colectomy but not for the long-term prognosis in cyclosporine A treatment for ulcerative colitis
Taku Kobayashi et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis
Xiangdong Liu et al.
NATURE GENETICS (2010)
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
Andre Franke et al.
NATURE GENETICS (2010)
TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages
Fabio Martinon et al.
NATURE IMMUNOLOGY (2010)
Targeting microRNAs in cancer: rationale, strategies and challenges
Ramiro Garzon et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
A Large-Scale, Consortium-Based Genomewide Association Study of Asthma
Miriam F. Moffatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Quantitive Cytokine mRNA Expression Profiles in the Colonic Mucosa of Patients with Steroid Naive Ulcerative Colitis During Active and Quiescent Disease
Reikei Matsuda et al.
INFLAMMATORY BOWEL DISEASES (2009)
Infliximab therapy decreases the levels of TNF- and IFN- mRNA in colonic mucosa of ulcerative colitis
Trine Olsen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer
Minoru Toyota et al.
CANCER RESEARCH (2008)
The interleukin-23 axis in intestinal inflammation
Philip P. Ahern et al.
IMMUNOLOGICAL REVIEWS (2008)
Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease
Steven A. McCarroll et al.
NATURE GENETICS (2008)
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
Jeffrey C. Barrett et al.
NATURE GENETICS (2008)
Inflammatory bowel disease: Progress and current concepts of etiopathogenesis
Franco Scaldaferri et al.
JOURNAL OF DIGESTIVE DISEASES (2007)
Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro:: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis
Federico Moriconi et al.
TRANSLATIONAL RESEARCH (2007)
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
Fanyin Meng et al.
GASTROENTEROLOGY (2007)
IL-1β genotype-related effect of prednisolone on IL-1β production in human peripheral blood mononuclear cells under acute inflammation
Svetlana Markova et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)
Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma
Miriam F. Moffatt et al.
NATURE (2007)
Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility
Miles Parkes et al.
NATURE GENETICS (2007)
MiRNAs in cancer: approaches, aetiology, diagnostics and therapy
Cherie Blenkiron et al.
HUMAN MOLECULAR GENETICS (2007)
A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1
Jochen Hampe et al.
NATURE GENETICS (2007)
Delayed-release Multi Matrix System (MMX (TM)) mesalazine
Paul L. McCormack et al.
DRUGS (2007)
Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis
RB Sartor
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2006)
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
P Rutgeerts et al.
GASTROINTESTINAL ENDOSCOPY (2006)
PPAR gamma as a new therapeutic in inflammatory bowel diseases
L. Dubuquoy et al.
GUT (2006)
Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody
IJ Fuss et al.
INFLAMMATORY BOWEL DISEASES (2006)
XBP-1 is required for biogenesis of cellular secretory machinery of exocrine glands
AH Lee et al.
EMBO JOURNAL (2005)
Effects of azathioprine and its metabolites on repair mechanisms of the intestinal epithelium in vitro
S Schroll et al.
REGULATORY PEPTIDES (2005)
Quantitative measurement of cytokine mRNA in inflammatory bowel disease:: relation to clinical and endoscopic activity and outcome
D Raddatz et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2005)
A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease
J Puleston et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis
IJ Fuss et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD
M Daperno et al.
GASTROINTESTINAL ENDOSCOPY (2004)
Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis
G Van Assche et al.
GASTROENTEROLOGY (2003)
Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis
L Dubuquoy et al.
GASTROENTEROLOGY (2003)
CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes
I Tiede et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
The use and analysis of microarray data
A Butte
NATURE REVIEWS DRUG DISCOVERY (2002)
Differential glucocorticoid effects on repair mechanisms and NF-κB activity in the intestinal epithelium
MN Göke et al.
REGULATORY PEPTIDES (2002)
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis
G D'Haens et al.
GASTROENTEROLOGY (2001)
Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor γ (BPARγ) heterodimer:: A basis for new therapeutic strategies
P Desreumaux et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Clinical pharmacokinetics of slow release mesalazine
M De Vos
CLINICAL PHARMACOKINETICS (2000)
Peroxisome proliferator-activated receptor-γ activators inhibit IFN-γ-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells
N Marx et al.
JOURNAL OF IMMUNOLOGY (2000)
Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism
JD Croxtall et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor γ (PPARγ) agonists -: PPARγ co-association with transcription factor NFAT
XY Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
